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Hippocampal interneurons comprise a diverse family of inhibitory neurons that are
critical for detailed information processing. Along with gamma-aminobutyric acid (GABA),
interneurons secrete a myriad of neuroactive substances via secretory vesicles but the
molecular composition and regulatory mechanisms remain largely unknown. In this study,
we have carried out an immunohistofluorescence analysis to describe the molecular
content of vesicles in distinct populations of hippocampal neurons. Our results indicate
that phogrin, an integral protein of secretory vesicles in neuroendocrine cells, is highly
enriched in parvalbumin-positive interneurons. Consistently, immunoelectronmicroscopy
revealed phogrin staining in axon terminals of symmetrical synapses establishing
inhibitory contacts with cell bodies of CA1 pyramidal neurons. Furthermore, phogrin is
highly expressed in CA3 and dentate gyrus (DG) interneurons which are both positive
for PV and neuropeptide Y. Surprisingly, chromogranin B a canonical large dense core
vesicle marker, is excluded from inhibitory cells in the hippocampus but highly expressed
in excitatory CA3 pyramidal neurons and DG granule cells. Our results provide the first
evidence of phogrin expression in hippocampal interneurons and suggest the existence
of molecularly distinct populations of secretory vesicles in different types of inhibitory
neurons.
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INTRODUCTION
GABAergic neurons in the mammalian central nervous system (CNS) comprise a number
of interneuronal subgroups that assemble into networks with specific synaptic properties and
functional roles (reviewed in Freund and Buzsáki, 1996; McBain and Fisahn, 2001; Klausberger
and Somogyi, 2008). A particularly vast heterogeneity of GABAergic cells has been reported
in the hippocampal region where different subtypes can de distinguished by their distinct
electrophysiological properties and specific neuropeptide content (Freund and Buzsáki, 1996;
McBain and Fisahn, 2001; Klausberger and Somogyi, 2008). Recent advances in understanding
neuropeptide signaling suggest that the interneuronal system of neuropeptides is crucial for
maintaining appropriate brain function. However, it is currently unknown how interneurons
regulate neuropeptide storage and release to modulate synaptic transmission and information
processing. This lack in our knowledge is in stark contrast to the detailed mechanistic insights
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into GABA exocytosis (Südhof, 2013). Thus, a better
understanding of the role of neuropeptide secretion in different
interneuron types is necessary to unveil their function in
regulating neuronal networks.
Neuropeptides and non-classical neurotransmitters are
generally stored, delivered, and secreted via Large Dense Core
Vesicles (LDCVs) which are described as large (70–150 nm)
vesicles commonly found at non-specialized release sites (Fried
et al., 1985; Zhu et al., 1986). Additionally, neuropeptides can be
found in medium sized vesicles (MDCVs; 60–100 nm) of 1/8 of
the volume of LDCVs and predominantly located at presynaptic
terminals (van den Pol, 2012). Despite the remarkable variability
of their cargo, LDCVs and MDCVs have been considered a
molecularly homogenous population constituted by common
integral proteins which can be found in both neuroendocrine
and nerve cells. This is the case of the calcium-activator proteins
for secretion (CAPS) and the chromogranin family (Speidel
et al., 2003; Machado et al., 2010; Bartolomucci et al., 2011).
Chromogranin B (ChB, a.k.a. secretogranin I) expression
has been reported in both neuroendocrine cells and neurons
(Fischer-Colbrie et al., 1985). Despite these commonalities in
molecular composition, different modes of neuropeptide vesicle
exocytosis have been reported in cortical and hippocampal
neurons where vesicles with distinct cargo undergo either
persistent or transient exocytosis (de Wit et al., 2006; Farina
et al., 2015).
Consistent with the notion of vesicle heterogeneity in the
CNS, the present work has revealed that different hippocampal
neurons exhibit distinct LDCV markers. Particularly, we have
found that phogrin (a.k.a IA2β and PTPRN2) is highly expressed
in parvalbumin positive interneurons (PV+). Phogrin is an
integral protein of LDCVs in neuroendocrine tissues (Wasmeier
and Hutton, 1996) and has been implicated in several roles of the
physiology of secretory vesicles including trafficking (Wasmeier
et al., 2002, 2005; Saito et al., 2011), exocytosis (Cai et al., 2004),
and endocytosis (Torii et al., 2005; Wasmeier et al., 2005). To
date phogrin has been widely used as one of the major auto-
antigens in diabetesmellitus type I (Kawasaki et al., 1996; Lu et al.,
1996) and in the CNS, phogrin expression has been proposed
to be developmentally regulated (Chiang and Flanagan, 1996).
Although the function of phogrin in nerve cells remains poorly
understood, phogrin disruptions have been linked to attention
deficits (Lionel et al., 2011), addiction and mood disorders (Yang
et al., 2011), Down Syndrome (Papoulidis et al., 2014) and
HOXA1 spectrum disorder (Abu-Amero et al., 2012) suggesting
a pivotal role in regulating brain development and function.
Here, we have combined electron microscopy,
immunohistofluorescence, and transgenic mice to reveal
that phogrin is differentially expressed in different subtypes
of hippocampal interneurons. Phogrin was found primarily
expressed in hippocampal PV+ cells but virtually absent from
somatostatin (SOM) and cholecystokinin (CCK) interneurons.
In addition to being cell specific, phogrin expression was cargo-
dependent, as it was also abundant in interneurons containing
NPY, especially in the CA3-DG area. Our findings indicate the
existence of different populations of secretory vesicles restricted
to particular neuronal subtypes, and that phogrin may serve
as a novel marker for specific interneuronal subgroups in the
hippocampus.
MATERIALS AND METHODS
Animals
Adult C5BL/6 wild-type mice were obtained from The Jackson
Laboratory. PVCre-Ai6 mice were generated by breeding
commercial PV-Cre mice (The Jackson Laboratory, J-008069)
with reporter Ai6 mice that express the fluorescent protein
ZsGreen1 upon Cre-mediated recombination (The Jackson
Laboratory, J-007906). All animals used in this study were males.
All animal procedures were performed in accordance of The
University of Maryland School of Medicine Institutional Animal
Care and Use Committee. The University of Maryland School
of Medicine Institutional Animal Care and Use Committee
approved the study. All efforts were made to minimize the
number of animals used and their suffering throughout the
experiments.
Immunohistofluorescence
Adult (P30–P60) C57BL/6 wild-type mice or PVCre-Ai6 mice
were fatally anesthetized and transcardially perfused with ice-
cold 4% paraformaldehyde in PBS. Brains were removed and
post-fixed overnight (o/n) at 4◦C in the same fixative solution.
Coronal brain slices of 30 µm were obtained in a KD-
400 vibrating microtome (IHC World), collected as floating
sections and blocked for 1 h and a half at room temperature
(RT) in a solution containing 0.3% Triton X-100 and 5%
NGS in PBS. After blocking, sections were incubated (o/n;
4◦C) with the following primary anti-bodies in a solution
containing 0.3% Triton X-100 and 1% NGS in PBS: Rabbit
anti-Phogrin (1:200; Torii et al., 2009); Mouse anti-Phogrin
(3 µg/mL; Sigma-Aldrich SAB1406349); Mouse anti-VAMP2
(1:200; Synaptic Systems 103211); Mouse anti-GAD67 (1:1000;
Sigma-Aldrich G5419); Rabbit anti-GAD67 (1.5 µg/mL; Boster
PA1036); Rabbit anti-NeuN (1:500; Cell Signaling 12943);
Rabbit anti-Chromogranin-B (1:200; Synaptic Systems 259103);
Rabbit anti-Neuropeptide Y (1:2000; Peninsula laboratories T-
4070); Rabbit anti-Somatostatin (1:1000; Peninsula laboratories
T-4103); Rabbit anti-Cholecystokinin (1:2000; Sigma-Aldrich
C2581). After five washes of 15min each in PBS containing 0.25%
Tween 20, the floating sections were incubated with specific
Alexa conjugated antibodies (1:200, Molecular Probes) in a PBS
solution containing 0.3% Triton X-100 and 1% NGS (for 2 h
at RT. Finally, sections were washed, and incubated with DAPI
(Sigma-Aldrich) for 10min andmounted. Sections were stored at
4◦C, and images were acquired on a Zeiss LSM510 Meta confocal
scanning microscope.
Immunohistochemistry for Electron
Microscopy
Electron microscopic examination of immunoreactivity for
phogrin in the mouse dorsal hippocampus was performed as
described previously using the pre-embedding immunogold
method (Luján et al., 1996). Briefly, free-floating sections were
incubated in 10% NGS diluted in TBS for 1 h at RT. Sections
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were then incubated for 48 h in a Mouse anti-Phogrin antibody
(Sigma-Aldrich SAB1406349) at a final protein concentration of
1–2 µg/ml diluted in TBS containing 1% NGS. After several
washes in TBS, sections were incubated for 3 h in goat anti-
mouse IgG coupled to 1.4 nm gold (Nanoprobes Inc., Stony
Brook, NY) diluted 1:100 in TBS containing 1% NGS. After
several washes in phosphate-buffered saline (PBS), the sections
were postfixed in 1% glutaraldehyde diluted in the same buffer
for 10 min. They were washed in double distilled water, followed
by silver enhancement of the gold particles with a HQ Silver
kit (Nanoprobes Inc., Stony Brook, NY). Then, sections were
treated with osmium tetraoxide (1% in 0.1M PB), block-stained
with uranyl acetate, dehydrated in graded series of ethanol
and flat-embedded on glass slides in Durcupan (Fluka) resin.
Regions of interest were cut at 70–90 nm on an ultramicrotome
(Reichert Ultracut E, Leica, Austria) and collected on 200-mesh
nickel grids. Staining was performed on drops of 1% aqueous
uranyl acetate followed by Reynolds’s lead citrate. Ultrastructural
analyses were performed in a Jeol-1010 electron microscope.
Measurements and Quantification
All quantifications were obtained from aminimum of 10 sections
from the dorsal hippocampus per mice. Immunofluorescence
was analyzed in the different hippocampal subregions [CA1,
CA2, CA3, and dentate gyrus (DG)] using approximately 20–
30 fields of view for each condition. Both the granular cell layer
and hilus were analyzed together and reported as the DG region.
Colocalization of phogrin with NeuN, GAD-67 and interneuron
markers was expressed as a percentage of number of positive
cells out of phogrin positive cells. Colocalization with VAMP2
and Chromogranin B, and that of GAD67 with Chromogranin
B, were expressed as Pearson’s correlation coefficient (Adler
and Parmryd, 2010). To this end, the Intensity Correlation
Analysis plugin in ImageJ (National Institutes of Health) was
used (Li et al., 2004), and rolling ball background subtraction was
applied to the images before processing. Fields of view containing
ventricles or dead pixels were digitally cropped for processing,
since it has been reported that this background pixels could yield
artifactual results (Nakamura et al., 2007). Absolute percentages
were estimated as the fraction of positive cells out of the total
number of cells (identified by nuclear DAPI staining) in a given
field of view. Normalized percentages were calculated as the
absolute percentage of phogrin+ cells divided by the absolute
percentage of GAD67+ cells for each hippocampal subregion. For
VAMP2-phogrin and Chromogranin B-phogrin colocalization
measurements, phogrin images were thresholded and a binary
mask was obtained. This mask was subsequently used to
analyze colocalization exclusively in those ROIs corresponding
to phogrin positive puncta. When cell densities were expressed as
a function of the overall number of cells, the Particle Analysis-
Nucleus Counter plugin was employed over the DAPI images
corresponding to each field of view; quantifications were then
visually surveyed, to assure the proper functioning of this plugin.
Phogrin Antibody Validation
The commercially available antibody mouse anti-Phogrin
(Sigma-Aldrich SAB1406349) primarily used in this study
was validated against the home-made antibody rabbit
anti-Phogrin generated by Torii et al. (2009). Double
immunohistofluorescence using both antibodies yielded a
Pearson’s coefficient of 0.84 ± 0.01, indicating a high degree
of colabeling of both antibodies in different hippocampal
subregions (Supplemental Figures 1, 2) and several other brain
regions (Supplemental Figure 3). Pearson’s coefficient was
calculated using the Intensity Correlation Analysis plugin as
described previously in Measurements and quantification.
Statistics
Data were analyzed using OriginPro 8.0 software. For statistical
purposes one-way ANOVA followed by Bonferroni’s test was
used. Differences were considered statistically significant when
p< 0.05 with a confidence limit of 95%. All values were expressed
as mean± S.E.M.
RESULTS
Interneurons Exhibit Different Vesicle
Markers than Excitatory Cells in the
Hippocampus
To identify the molecular composition of secretory vesicles
in different hippocampal interneuron subtypes, we started
by characterizing the expression pattern of canonical LDCV
markers CAPS-1 and chromogranin B (Speidel et al., 2003;
Machado et al., 2010). According to previous work in primary
cultured neurons (Farina et al., 2015), immunohistofluorescence
analysis in adult mouse slices revealed high levels of CAPS-1
(Supplemental Figure 4) supporting the notion that this protein
is associated with neuronal LDCVs. As expected, CAPS-1 was
broadly expressed in the hippocampus showing no particular
cell-specificity. This was in contrast to chromogranin B staining
which was abundant in neurons of the CA3 stratum pyramidale,
stratum lucidum and in both the hilar region and the molecular
layer of the DG (analyzed together as the whole DG region), but
mostly absent from the CA1 and CA2 subregions (Figure 1A)
consistently with previous reports (Kroesen et al., 1996; Nicolay
et al., 2007).
Surprisingly, double labeling of chromogranin B and anti-
GAD67 to identify GABAergic neurons (Kanaani et al., 2010)
yielded a low mean Pearson’s coefficient value (0.12 ± 0.02;
n = 48 fields; given the low expression levels of chromogranin
B in the CA1 and CA2 regions, the mean coefficient value
was obtained only from CA3 and DG regions) (Figures 1B–D).
Our results indicate that both LDCV-associated proteins CAPS-
1 and chromogranin B are not highly expressed in hippocampal
interneurons. Particularly chromogranin B, which is primarily
absent fromGAD67 positive neurons, is unlikely to be an integral
component of neuropeptide-containing vesicles in inhibitory
cells. These results suggest that interneuronal LDCVs may
contain different molecular constituents.
Phogrin: A Vesicle Marker of Hippocampal
Interneurons
Given that commonly used LDCVs markers like CAPS-1
and chromogranin B cannot be used to definitely identify
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FIGURE 1 | Endogenous Chromogranin B is not detected in GAD67+ Cells. (A) Distribution of endogenous Chromogranin B immunolabeling in the adult
mouse hippocampus. Scale bar represents 100 µm. (B) Immunohistofluorescence analysis in CA3 and DG of the expression pattern of GAD67 and Chromogranin B
showing a marked segregation in hippocampal tissue. Arrow heads indicate Chromogranin B−/GAD67+ cells. Left-bottom boxes show a magnified view of the area
of interest delimited by the smaller box. Scale bar represents 40µm. (C) Chromogranin B and GAD67 labeling and colocalization map obtained from ImageJ Intensity
Correlation Analysis plugin. Scale bar represents 40 µm. (D) Mean Pearsons’ correlation coefficient for GAD67 and Chromogranin B obtained from several CA3 and
DG fields (Mean coefficient value = 0.12 ± 0.02; n = 48 fields).
secretory vesicles in hippocampal interneurons, we reasoned
that interneuronal vesicles may present a distinct molecular
composition. We tested phogrin, a transmembrane protein
of neuroendocrine vesicles which has been detected during
early developmental stages of brain formations that give
rise to inhibitory neurons (Chiang and Flanagan, 1996).
Because phogrin has been seldom probed in neuronal tissue,
we analyzed phogrin expression using electron microscopy
and immunohistofluorescence with two different antibodies.
Commercially available Mouse anti-Phogrin (Sigma Aldrich
SAB1406349) was tested against a Rabbit anti-Phogrin validated
by Torii and colleagues for electron microscopy of pancreatic
tissue (Torii et al., 2009). As described in Materials and
Methods, both antibodies showed nearly identical labeling
patterns (Pearson’s coefficient of 0.84 ± 0.01), indicating a high
degree of co-labeling in the hippocampus (Supplemental Figures
1, 2) and several other brain regions (Supplemental Figure 3).
Immunohistofluorescence using a commercially available
antibody, revealed that phogrin was expressed in discrete
cells through all hippocampal regions analyzed (CA1,
CA2, CA3 and DG). Phogrin labeling was observed in the
stratum oriens, stratum radiatum and in the upper layer of
Frontiers in Cellular Neuroscience | www.frontiersin.org 4 August 2016 | Volume 10 | Article 202
Ramírez-Franco et al. Phogrin Is Expressed in Parvalbumin-Positive Interneurons
stratum pyramidale (Supplemental Figure 2). Using double
immunohistofluorescence against phogrin and the specific
neuronal marker NeuN we confirmed that phogrin expression
was limited to neurons in the different hippocampal subregions
(colocalization percentages: CA1: 100 ± 0%; CA2: 100 ± 0%;
CA3: 93.75 ± 4.58%; DG: 100 ± 0%; 91 NeuN+ cells out of 94
phogrin+ cells; Figures 2A,B). The morphology and localization
of phogrin+ neurons suggested that phogrin may be primarily
expressed in interneurons. To confirm this possibility we
performed double immunohistofluorescence against phogrin
and the GABAergic neuron marker GAD67. Surprisingly, the
vast majority of phogrin-expressing neurons were GAD67
positive cells suggesting phogrin is a specific marker for
interneuronal vesicles in the hippocampus (Normalized
percentage as a fraction of GAD67+ cells: CA1: 92.54 ± 2.86%;
CA2: 90.10 ± 5.34%; CA3: 90.20 ± 3.45%; DG: 77.38 ± 6.46%;
171 GAD67+ cells out of 197 phogrin+ cells; Figures 2C,D).
Since most of phogrin+ neurons were also GAD67+ cells, we
quantified the density of phogrin+ neurons as a fraction of the
densities of GAD67+ cells. We found no differences between
the densities of phogrin+ cells expressed as a percentage of
GAD67+ cells throughout the different hippocampal regions
(colocalization percentages: CA1: 42.40 ± 4.15%; CA2: 44.79 ±
5.76%; CA3; 55.58 ± 4.38%; DG: 49.96 ± 4.30%; Figures 2E,F).
Our data indicate that contrary to previous suggestions (Chiang
and Flanagan, 1996), phogrin expression is abundant in the
adult hippocampus and other brain regions (Supplemental
Figures 2, 3). More importantly, phogrin is selectively expressed
in inhibitory neurons which is suggestive of a specific role
in the regulation of interneuronal vesicles in the postnatal
hippocampus.
Phogrin does Not Colocalize with the
Canonical LDCVs Marker Chromogranin B
Consistent with selective labeling of phogrin in hippocampal
interneurons, we found a completely separation in the expression
pattern of phogrin and chromogranin B in both puncta and
somatic regions (Figures 2G–I) (Mean Pearsons’ coefficient
value: Somas = 0.04 ± 0.04; Puncta = 0.05 ± 0.03). Mean
Pearsons’ coefficient value was calculated in both CA3 and
DG since chromogranin B was undetectable in CA1 and CA2
regions (Figure 1A). These results suggest that phogrin and
chromogranin B are segregated in unique subpopulations of
vesicles specific to inhibitory or excitatory hippocampal neurons,
respectively.
Subcellular Expression of Phogrin in
Hippocampal Interneurons
Given that the subcellular expression of phogrin in the postnatal
brain has been seldom explored, we performed immunolabeling
using a pre-embedding immunogold method in the CA1 region
of the hippocampus (Figure 3A). Immunoparticles for phogrin
were mainly located at presynaptic sites in axon terminals of
basket cells establishing inhibitory synaptic contacts with the
cell body of pyramidal cells. Furthermore, phogrin labeling
was never detected in axon terminals establishing excitatory
synapses recognized by the presence of a prominent postsynaptic
density in the postsynaptic element. A significant proportion of
immunoparticles for phogrin were also detected at postsynaptic
sites in dendritic shafts of interneurons, as well as associated
with the rough endoplasmic reticulum in the cell body of
interneurons. We expanded our analysis by performing double
immunofluorescence against phogrin and the synaptic vesicle
protein VAMP2. VAMP2 (a.k.a synaptobrevin-2) is an integral
component of the SNARE complex required to exocytose vesicles
thus can be used to detect presynaptic localizations enriched
with fast neurotransmitter-containing vesicles (Südhof, 2013).
Additionally, VAMP2 can also be part of postsynaptic membrane
compartments where can mediate activity-dependent exocytic
events at dendrites (Jurado et al., 2013; Jurado, 2014). Both
VAMP2 and phogrin showed a punctuated labeling typical
of membrane associated-proteins (Figure 3B). Agreeing with
previous findings in rat primary hippocampal neurons (Jiang
et al., 1998), VAMP2 and phogrin exhibited a high degree
of colocalization in punctate regions but also in the somas
(Figure 3C; Mean Pearsons’ coefficient values: Somas = 0.70
± 0.03; Puncta = 0.63 ± 0.02). The subcellular expression of
phogrin-containing vesicles points to the possibility that these
vesicles may coexist with small synaptic vesicles at presynaptic
sites but also be stored at non-canonical sites like postsynaptic
localizations.
Phogrin Is a Selective Marker of PV and
NPY Interneurons
Given the prevalent expression of phogrin in GAD67+ neurons,
we sought to identify which interneuron subtypes may selectively
exhibit this newly characterized vesicle marker. Firstly, we carried
out double staining between phogrin and CCK-containing
interneurons (CCK), a subclass of basket cell interneurons which
almost exclusively project to the stratum pyramidale (Klausberger
and Somogyi, 2008). Strikingly, CCK+ interneurons showed a
total absence of phogrin in all hippocampal subregions analyzed
(Figure 4; percentage of CCK+ cells out of phogrin+ cells: CA1:
0.00 ± 0.00%; CA2: 8.82 ± 6.41%; CA3: 4.32 ± 2.60%; DG: 0.00
± 0.00%; 5 CCK+ cells out of 132 phogrin+ cells). Extended
characterization to somatostatin positive (SOM+) interneurons,
another prominent class of basket cells in the hippocampus,
revealed almost identical phogrin exclusion (Figure 5; percentage
of SOM+ cells out of phogrin+ cells: CA1: 7.14 ± 5.00%;
CA2: 0.00 ± 0.00%; CA3: 7.50 ± 5.09%; DG: 0.00 ± 0.00%;
6 SOM+ cells out of 49 phogrin+ cells). These results indicate
that phogrin expression is restricted to subpopulations of
hippocampal interneurons.
Since GAD67 expression is preferentially associated to
PV+ interneurons (Fukuda et al., 1997), we hypothesized that
phogrin may be restricted to this interneuronal population.
To better address this possibility, we performed single
immunohistofluorescence against phogrin in PVCre-Ai6
mice to identify PV-containing neurons. Consistently, we found
that most of the phogrin-expressing interneurons were PV+ in
all the hippocampal regions examined (Figure 6; percentage of
PV+ cells out of phogrin+ cells: CA1: 72.08± 6.17%; CA2: 79.79
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FIGURE 2 | Phogrin is primarily expressed in interneurons. (A) Phogrin positive neurons express the pan neuronal marker NeuN. Scale bars represent 40 µm.
(B) Quantification of NeuN expression in phogrin+ cells. Virtually all analyzed phogrin+ cells expressed NeuN (91 out of 94 cells). (C) Phogrin positive neurons
co-express the interneuronal marker GAD67. Scale bars represent 40 µm. (D) Quantification of GAD67 expression in phogrin+ neurons. The vast majority
(Continued)
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FIGURE 2 | Continued
of phogrin positive neurons were found to be GAD67+ (171 out of 197 cells) and no statistical differences were found between different hippocampal subregions. (E)
Absolute percentages of GAD67 (black and gray bars) and phogrin (red bars) positive cells over the total number of cells measured as the total number of DAPI
stained nuclei (624 GAD67+ cells and 248 phogrin+ cells out of 21,179 cells; *p < 0.05). (F) Percentage of phogrin+ cells normalized to the percentage of GAD67+
cells in each hippocampal subregion. One-way ANOVA followed by Bonferroni’s test for means comparison; all the possible comparisons are non-significant. (G)
Phogrin positive neurons lack Chromogranin B expression in CA3. Scale bar represents 40 µm. Chromogranin B expression is also absent in DG phogrin+ neurons.
Scale bar represents 20 µm. (H) Colocalization map obtained after running Intensity Correlation Analysis Plugin in Image J. (I) Mean Pearsons’ correlation coefficient
for phogrin and Chromogranin B from several CA3 and DG fields (Mean coefficient values: Somas = 0.04 ± 0.04; Puncta = 0.05 ± 0.03; Two sample t-test for mean
comparison, p = 0.87; Somas n = 7 fields; Puncta n = 11 fields). Boxes within A,C,G,H show a magnified view of the area of interest delimited by the smaller box.
± 5.25%; CA3: 69.36 ± 7.24%; DG: 70.73 ± 5.56%; 225 PV+
cells out of 311 phogrin+ cells). Intriguingly, phogrin did not
colocalize with PV+ interneurons in cortical areas (Supplemental
Figure 5) suggesting that phogrin presence in these interneuronal
subtype is region-specific. Lastly, we explored the colocalization
of phogrin with NPY, another prominent peptidergic marker
of hippocampal interneurons (Freund and Buzsáki, 1996).
We also observed strong colocalization between phogrin and
NPY-expressing cells (Figure 7). Interestingly, the colocalization
percentage of phogrin and NPY showed a gradual increase
along different hippocampal subregions with the highest level
of colocalization in the DG region (Figure 7; percentage of
NPY+ cells out of phogrin+ cells: CA1: 34.91 ± 7.24%; CA2:
29.33 ± 9.43%; CA3: 54.16 ± 6.94%; DG: 80.83 ± 6.81%; 73
NPY+ cells out of 156 phogrin+ cells). Since we have found
that phogrin expression is fairly homogenous throughout the
different hippocampal subregions (Supplemental Figure 2), the
increase in the colocalization ratio between phogrin and NPY
may be likely due to higher levels of NPY expression in the DG
(Deller and Leranth, 1990; Gruber et al., 1994). Finally, we tested
the percentage of NPY+ cells that also were PV+. As expected,
the degree of colocalization was high (Figure 8A) and increased
following the same pattern of phogrin and NPY co-expression
(Figure 8B; Percentage of NPY+ cells out of PV+ cells: CA1:
14.93 ± 3.64%; CA2: 4.95 ± 1.70%; CA3: 39.75 ± 5.45%; DG:
62.78 ± 6.50%; 99 NPY+ cells out of 393 PV+ cells). Since
PV+ and NPY+ interneurons are thought to belong to unique
interneuronal populations, the addition of the colocalization
percentages of PV+ cells / Phogrin+ cells and NPY+ cells /
Phogrin+ cells was expected to be 100% maximum. Surprisingly,
added percentages in CA3 and DG subregions were higher
than 100% (Figure 8C) suggesting that a significant percentage
of interneurons in these hippocampal regions contain both
markers. Our findings indicate that phogrin is differentially
expressed in a specific subgroup of basket cells which suggest
a distinct molecular composition of neurosecretory vesicles in
peptidergic hippocampal interneurons. Given its high specificity,
phogrin can be used as a novel marker to identify PV-containing
neurons in the whole hippocampus and NPY-containing PV+
cells in the CA3 and DG subregions.
DISCUSSION
Interneurons are often classified according to neuropeptide
content which usually concurs with distinct electrophysiological
properties (reviewed in Freund and Buzsáki, 1996; McBain and
Fisahn, 2001; Klausberger and Somogyi, 2008). However, it is
becoming increasingly clear that interneuronal neuropeptides are
more than convenient neurochemical markers and can act as
important modulators of neuronal activity (Baraban and Tallent,
2004). In particular, interneuronal neuropeptides appear to play
roles in cognition (Dutar et al., 2002) and as endogenous anti-
epileptic agents (Erickson et al., 1996). Although neuropeptide
release underlies the integrative role of interneurons, it is still
unclear how specific neuropeptide content mediates interneuron
function. In answering this question, it is important to elucidate
the mechanisms of neuropeptide storage and secretion in distinct
interneuronal subtypes.
Neuropeptides are confined to specialized vesicles (LDCVs
and MDCVs) which are often released at non-canonical release
sites in a slowermanner than traditional neurotransmitters (Fried
et al., 1985; Zhu et al., 1986; van den Pol, 2012). Most of
our knowledge of the molecular composition and exocytosis of
secretory vesicles comes from studies in neuroendocrine tissue
where a number of markers have been identified. Thus, the
chromogranin family (a.k.a. secretogranins) and CAPS have been
found in both endocrine and neuronal tissue (Speidel et al., 2003;
Machado et al., 2010; Bartolomucci et al., 2011). These findings
pointed to the notion that despite the striking diversity of cargo,
neuronal secretory vesicles may exhibit a fairly homogenous
molecular composition. In contrast to this convention, our data
demonstrates that different interneuronal types exhibit distinct
vesicle markers (for a summary see Table 1).
Using a combination of electron microscopy,
immunohistofluorescence and transgenic mice, we have
shown that chromogranin B, a canonical LDCV marker,
is not expressed in GAD67+ neurons in the hippocampus
(Figures 1B–D). Surprisingly, phogrin a receptor-type protein
tyrosine phosphatase which has been extensively studied in
endocrine cells (Wasmeier and Hutton, 1996; Wasmeier et al.,
2002, 2005; Torii et al., 2005, 2009) was found highly expressed
in specific subtypes of hippocampal interneurons (Figures 4–8).
Although, phogrin in the mammalian CNS has been previously
reported (Chiang and Flanagan, 1996), its neuronal expression
pattern and subcellular distribution have been only tangentially
addressed. To the best of our knowledge this is the first report
to identify phogrin expression in hippocampal interneurons.
Furthermore, our findings clearly demonstrate that phogrin
is highly expressed in PV+ interneurons throughout different
hippocampal regions. These findings are consistent with the
presence of phogrin mRNA in the primordial Medial Ganglionic
Eminence (MGE) (Chiang and Flanagan, 1996) that supplies the
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FIGURE 3 | Subcellular expression of phogrin in hippocampal interneurons. (A) Immunoreactivity for phogrin in the CA1 region of the hippocampus as
revealed using a pre-embedding immunogold method. Immunoparticles for phogrin (black dots) were mainly located at presynaptic sites in button terminals (bt)
(Continued)
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FIGURE 3 | Continued
opposing the cell body of pyramidal cells (arrow heads). Immunoparticles for phogrin were never detected in axon terminals of excitatory synapses recognized by the
presence of a prominent postsynaptic density. A significant proportion of immunoparticles for phogrin (arrows) were also detected at postsynaptic sites in dendritic
shafts (Den) of interneurons, as well as associated with the rough endoplasmic reticulum (large arrow heads). Cyt, cytoplasm; Nu, nucleus. Scale bars represent 0.5
µm. (B) Endogenous phogrin is co-expressed with VAMP2 in cell somas of stratum oriens and in puncta in stratum pyramidale in axo-somatic contacts. Scale Bar
represents 5 µm. (C) Pearsons’ correlation coefficients for VAMP2 and phogrin colocalization in both somas of stratum oriens and puncta in stratum pyramidale.
(Mean coefficient values: Somas = 0.70 ± 0.03; Puncta = 0.63 ± 0.02. Two sample t-test for mean comparison, p = 0.18; Somas n = 4 fields; Puncta n = 14 fields).
TABLE 1 | Summary of colocalization percentage and Pearson’s correlation coefficient for different markers used in this study.
Colocalization method
Marker
Region
CA1 CA2 CA3 DG
Colocalization percentage NeuN:Phogrin 100±0.00% 100± 0.00% 93.75±4.58% 100± 0.00%
GAD67:Phogrin 92.54±2.86% 90.10± 5.34% 90.20±3.45% 77.38± 6.46%
CCK:Phogrin 0.00±0.00% 8.82± 6.41% 4.32±2.60% 0.00± 0.00%
SOM:Phogrin 7.14±5.00% 0.00± 0.00% 7.50±5.09% 0.00± 0.00%
PV:Phogrin 72.08±6.17% 79.79± 5.25% 69.36±7.24% 70.36± 5.56%
NPY:Phogrin 34.91±7.24% 29.33± 9.43% 54.16±6.94% 80.83± 6.81
NPY:PV 14.93±3.64% 4.95± 1.70% 39.75±5.45% 62.78± 6.50%
Pearson’s correlation coefficient RαPhogrin:MαPhogrin 0.84 ± 0.01
ChromograninB:GAD67 n/a n/a 0.12 ± 0.02
SOMAS PUNCTA
Phogrin:ChromograninB 0.04 ± 0.04 0.05 ± 0.03
Phogrin:VAMP2 0.70 ± 0.03 0.63 ± 0.02
vast majority of PV+ hippocampal and cortical interneurons
(Tricoire et al., 2011). Intriguingly, our preliminary data suggest
that phogrin colocalizes with PV+ cells exclusively in the
hippocampus (Supplemental Figure 5). These results indicate
that although their common origin, PV+ interneurons may
exhibit different molecular content in a region-specific manner
that may be related to distinct functionality. Furthermore,
phogrin expression was tightly confined to a specific subset of
interneurons since SOM+ and CCK+ cells, other prominent
basket cell types in the hippocampus, lack phogrin expression
altogether (Figures 4, 5). These results are in contrast with
previous studies in neurosecretory cells of the gastrointestinal
tract, in which phogrin can be found in both SOM+ and CCK+
cells (Gomi et al., 2013) suggesting that phogrin expression is
regulated in a tissue-specific manner.
Consistent with molecularly distinct pools of secretory
vesicles, phogrin and chromogranin B, appeared markedly
segregated in hippocampal neurons, with chromogranin B
mainly confined to excitatory CA3 and DG neurons (Figures 1,
2). This segregated expression may not be exclusive to the
mouse hippocampus as insulin-containing vesicles in pancreatic
β-cells mostly contain phogrin with just a small fraction of
vesicles with detectable chromogranin B (Giordano et al., 2008).
These data indicate that different neuronal populations display
distinct LDCVs with non-overlapping molecular markers. In
interpreting these results it is important to consider that while
our immunohistofluorescence approach allows us to assess
endogenous phogrin without the confounding of overexpression,
it is limited by antibody specificity and sensitivity. In order
to overcome these limitations, we have used two antibodies to
confirm the expression of phogrin in hippocampal interneurons
(Supplemental Figure 1). Antibody characterization confirms
that both a commercially available antibody and an antibody
generated for electron microscopy experiments by Torii et al.
exhibit indistinguishable staining patterns (Supplemental Figure
1). Even so, we cannot rule out the presence of phogrin,
although to a lesser extent, in excitatory neurons. However, the
absence of chromogranin B in PV+ interneurons is strengthened
by the undetectable levels of this protein in GAD67+ cells.
Within inhibitory neurons, phogrin-containing vesicles exhibit
a ubiquitous expression in both axon terminals and somato-
dendritic compartments. Double immunohistofluorescence of
VAMP2 and phogrin showed high colocalization levels in regions
showing a punctate pattern of staining (Figures 3B,C) according
to phogrin immunoparticles at axon terminals (Figure 3A).
Additionally, a significant proportion of immunoparticles for
phogrin were found at postsynaptic sites in dendritic shafts
of interneurons suggesting that phogrin-containing vesicles
may be stored at both presynaptic and postsynaptic regions.
A postsynaptic location of phogrin is not surprising since
somato-dendritic exocytosis has been described for many
neuromodulators (Fried et al., 1985; Zhu et al., 1986; van den Pol,
2012).
A pressing question is the function of phogrin in regulating
vesicle dynamics in hippocampal interneurons. Previous studies
in neuroendocrine cells and neurons proposed diverse roles of
phogrin in LDCVs trafficking (Wasmeier et al., 2002, 2005;
Saito et al., 2011), exocytosis (Cai et al., 2004), endocytosis
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FIGURE 4 | Phogrin does not colocalize with CCK-positive interneurons in the hippocampus. (A) Phogrin is not co-expressed with CCK in CA1, CA2, CA3,
or DG. Rigth-top boxes within each panel show a magnified view of the area of interest delimited by the smaller box. Scale bars represent 40 µm. (B) Colocalization
percentage of phogrin+ and CCK+ interneurons throughout different hippocampal subregions (5 CCK+ cells out of 132 phogrin+ cells). Non-significant statistical
differences were found between subregions. One-way ANOVA followed by Bonferroni’s test for means comparison; all the possible comparisons are non-significant.
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FIGURE 5 | Phogrin does not Colocalize with SOM-positive Interneurons in the Hippocampus. (A) Phogrin is not co-expressed with SOM in CA1, CA2, CA3,
or DG. Scale bars represent 40 µm. Rigth-top boxes within each panel show a magnified view of the area of interest delimited by the smaller box. (B) Colocalization
percentage of phogrin+ and SOM+ interneurons throughout different hippocampal subregions (6 CCK+ cells out of 49 phogrin+ cells). Non-significant statistical
differences were found between subregions. One-way ANOVA followed by Bonferroni’s test for means comparison; all the possible comparisons are non-significant.
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FIGURE 6 | Phogrin is highly expressed in PV-positive interneurons in the hippocampus. (A) Phogrin is co-expressed with PV in CA1, CA2, CA3, or DG.
Arrow heads indicate phogrin−/PV+ interneurons. Rigth-top boxes within each panel show a magnified view of the area of interest delimited by the smaller box. Scale
bars indicate 40 µm. (B) Colocalization percentage of phogrin+ and PV+ interneurons throughout different hippocampal subregions (225 PV+ cells out of 311
phogrin+ cells; n = 49 fields). Non-significant statistical differences were found between subregions. One-way ANOVA followed by Bonferroni’s test for means
comparison; all the possible comparisons are non-significant.
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FIGURE 7 | Phogrin and NPY show a region-dependent pattern of colocalization. (A) Phogrin is partially co-expresssed with NPY in CA1 and CA2 in contrast
to the high degree of colocalization in CA3 and DG. Arrow heads indicate phogrin−/NPY+ interneurons. Rigth-bottom boxes within each panel show a magnified view
of the area of interest delimited by the smaller box. Scale bars represent 40 µm. (B) Colocalization percentage of phogrin+ and NPY+ interneurons throughout
different hippocampal subregions (73 NPY+ cells out of 156 phogrin+ cells; *p < 0.05). One way ANOVA followed by Bonferroni’s test for means comparison;
non-statistical significant comparisons are not indicated in the graph for clarity.
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FIGURE 8 | A specific subpopulation of PV+ interneurons also contains NPY. (A) NPY is partially co-expresssed with PV in CA3 and DG but not in CA1 and
CA2 subregions. Arrow heads indicate PV−/NPY+ interneurons. Left-bottom boxes within each panel show a magnified view of the area of interest delimited by the
smaller box. Scale bars represent 40 µm. (B) Colocalization percentages of NPY and PV in different hippocampal subregions (99 NPY+ cells out of 393 PV+ cells;
*p < 0.05). (C) Bar graph represents overlapping mean colocalization percentages of phogrin+/NPY+ and PV+/NPY+ interneurons throughout different hippocampal
subregions. Note that the value is greater than 100% in CA3 and DG. One way ANOVA followed by Bonferroni’s test for means comparison; non-statistical significant
comparisons are not indicated in the graph for clarity.
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(Torii et al., 2005; Wasmeier et al., 2005), and cargo loading
(Henquin et al., 2008). Our data indicates phogrin may regulate
distinctive functions depending on neuronal type and cargo
content. Furthermore, taken together the observed cellular
specificity of phogrin and chromogranin B challenges the
classic view of secretory vesicles as molecularly homogenous
vesicles. According to this, distinct modes of LDCVs exocytosis,
transient and persistent, have been described in cortical and
hippocampal neurons (de Wit et al., 2009; Farina et al., 2015)
implying the existence of different LDCVs pools in a similar
fashion to small synaptic vesicles. In addition to the molecular
composition, the balance between transient and persistent release
may also be determined by LDCVs cargo (de Wit et al.,
2009).
Interestingly, we have found that a vast majority of phogrin+
cells in CA3 and DG neurons colocalized with NPY and that
most of these neurons were also PV+ in a region-specific manner
(Figures 7, 8). A potential explanation for the region specificity is
that since both phogrin and PV expression is fairly homogenous
throughout the different hippocampal subregions, the increase
in the colocalization ratio may be likely reflecting the higher
levels of NPY expression in the DG, which is well-characterized
(Deller and Leranth, 1990; Gruber et al., 1994). In this scenario,
the higher ratio of colocalization in CA3 and DG neurons may
just be reflecting the higher probability of NPY expression in
these cells. Nonetheless, increasing numbers of NPY+ and PV+
interneurons is expected to have an impact in the regulation
of excitatory synaptic transmission and information processing
in these hippocampal subregions. Thus, NPY in the DG has
been proposed to be an important factor in the modulation of
epilepsy (Erickson et al., 1996; Klapstein and Colmers, 1997;
Gariboldi et al., 1998). Given the high levels of colocalization
of phogrin with NPY, it would be interesting to address the
potential implication of this protein in regulating NPY levels and
its relationship to epileptic seizures. An interesting hypothesis
would be that phogrin mediates NPY secretion in the hilar
hippocampal region. In this scenario, phogrin loss of function
may lead to aberrant hyperexcitability due to decreased levels of
NPY. Therefore, cargo-specificity may be related with phogrin
function in the adult hippocampus in the same manner as
has been shown in neurosecretory cells (Henquin et al., 2008).
Undoubtedly, further experiments will be necessary to elucidate
the role of phogrin in hippocampal neurons and secretory vesicle
dynamics. Nonetheless, the identification of phogrin as a specific
marker of vesicles in inhibitory cells in the mouse hippocampus
will be a highly valuable new tool for the study of the role
of interneuronal neuropeptide secretion in regulating neuronal
networks.
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